Inhibikase Therapeutics, Inc. (IKT): Revenue
$0
Year ended 2024-12-31
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $0 | -100.0% | 2025-03-27, From 2024-01-01 |
| 2023-12-31 | $260.5K | +111.0% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $123.4K | -96.0% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $3.10M | +343.9% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $698.5K | n/a | 2022-03-31, From 2020-01-01 |